News Releases

Date	Title	Document
Date May 05, 2020	Title Oncocyte Announces Peer-Reviewed Publication of Data Demonstrating the Potential of its TNBCType Assay to Inform Triple Negative Breast Cancer Drug Development	Document PDF
Date May 05, 2020	Title Oncocyte to Report First Quarter 2020 Financial Results on Tuesday, May 12	Document PDF
Date May 01, 2020	Title Oncocyte Announces the Publication of New Long-Term Patient Follow Up Data for DetermaRx™ and Research Describing the IRENE Cohort Being Used in the Development of DetermaDx™	Document PDF
Date Apr 30, 2020	Title Oncocyte Announces Final Medicare LCD from Palmetto for DetermaRx™	Document PDF
Date Apr 24, 2020	Title Oncocyte Announces $10.7 Million Registered Offering	Document PDF
Date Apr 23, 2020	Title Oncocyte Announces Distribution Agreement with CORE Diagnostics, Expanding Commercial Availability of DetermaRx™ to India, the Middle East and Africa	Document PDF
Date Apr 07, 2020	Title Oncocyte to Participate at 19th Annual Needham Virtual Healthcare Conference	Document PDF
Date Mar 25, 2020	Title ONCOCYTE PROVIDES CORPORATE UPDATE AND REPORTS FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS	Document PDF
Date Mar 19, 2020	Title Oncocyte Announces the Launch of CLIA-validated DetermaIO™, a Novel Gene Expression-Based Immune Therapy Response Predictor, for Research Use by Biopharmaceutical Companies and Researchers	Document PDF
Date Mar 18, 2020	Title ONCOCYTE TO REPORT FOURTH QUARTER AND FISCAL 2019 FINANCIAL RESULTS ON WEDNESDAY, MARCH 25	Document PDF